Key figures
-
21.2
billion euro net sales in 2024
-
6.1
billion euro EBITDA pre in 2024
-
62000
employees around the world
Latest News
View all news-
Press Releases
EMD Serono Presents Results on Efficacy and Safety of Enpatoran in SLE at EULAR ...
Company presents phase 2 data of enpatoran in systemic lupus erythematosus, highlighting improved efficacy in patients with active skin manifestations
2025/06/12
-
Press Releases
China’s Center for Drug Evaluation Accepts Merck KGaA, Darmstadt, Germany’s ...
The Center for Drug Evaluation of the China National Medical Products Administration officially accepted the application for pimicotinib for TGCT.
2025/06/10
-
Press Releases
Pimicotinib Demonstrates Best-in-Class Potential with Significant Efficacy ...
Merck KGaA, Darmstadt, Germany, today announced the presentation of detailed positive results from Part 1 of the global Phase 3 MANEUVER trial evaluating pimicotinib in TGCT.
2025/05/28
Stay up-to-date
You want to receive the latest information about our company by e-mail? Then subscribe to our press releases: Subscribe
-
Media Contacts
Get in touch!for journalists, bloggers or multipliers.
-
Media downloads
Browse and download high-quality images and video footage.Access gallery -
Press Kits
Collected Topicswith all the facts and relevant background information on particularly important topics.
This might also interest you
-
Strategy & Values
Learn moreWe believe in science and technology as a force for good.
-
Stories
Learn moreLearn more about our company and the people behind it.
-
Sustainability
Learn moreWe want to create long-term added value for society.
-
Our sites
Learn moreLearn where you can find us around the world.
EVEN MORE INFORMATION
Upcoming Events
View All EventsOur Q2 2025 results will be published on August 7, 2025, at 7 a.m. (CEST). Our conference call for the media will take place at 10:00 a.m. (CEST), and the conference call for analysts at 2 p.m. (CEST).
Our Q3 2025 results will be published on November 13, 2025, at 7 a.m. (CET). Our conference call for the media will take place at 10:00 a.m. (CET), and the conference call for analysts at 2 p.m. (CET).